Yangzhou, China, August 11th, 2023 – Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA).
See the attachment for details.
Successful FDA inspection at Aurisco’s manufacturing site in Yangzhou, China